Market Outlook
The global Artificial Heart Lung Machines market size was valued at USD 286 million in 2022 and is forecast to a readjusted size of USD 369.7 million by 2029 with a CAGR of 3.7% during review period.
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.
This report is a detailed and comprehensive analysis for global Artificial Heart Lung Machines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Artificial Heart Lung Machines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Artificial Heart Lung Machines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Artificial Heart Lung Machines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Artificial Heart Lung Machines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Heart Lung Machines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Heart Lung Machines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Segmentation By Type
Single Roller Pump HLM
Double Roller Pump HLM
Segmentation By Application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Artificial Heart Lung Machines Market in 2025?
Advancements in technology have significantly improved the efficiency and reliability of artificial heart-lung machines. The growing prevalence of heart and lung diseases, coupled with an increase in the number of cardiac surgeries, supports the market’s growth. Additionally, innovations in minimally invasive procedures and the development of smaller, more portable devices are expected to drive market expansion.
What are the weaknesses of the Artificial Heart Lung Machines Market in 2025?
High costs of manufacturing and maintenance of heart-lung machines may limit adoption, especially in low-resource settings. Furthermore, the complexity of operating these machines requires skilled professionals, leading to challenges in training and ensuring a consistent quality of care.
What are the opportunities in the Artificial Heart Lung Machines Market in 2025?
With an aging global population, the demand for heart-lung machines is expected to rise. Emerging markets, where healthcare infrastructure is improving, represent a significant growth opportunity. Additionally, research into more advanced, bio-compatible materials and integration with artificial intelligence (AI) for monitoring and decision-making could open new avenues for innovation.
What are the threats to the Artificial Heart Lung Machines Market in 2025?
The market faces threats from potential technological failures, including machine malfunctions during surgeries. Regulatory challenges and the long approval times for new devices can delay innovation. There is also competition from alternative medical technologies, such as ventricular assist devices, which might limit the market’s potential growth.
Market PESTEL Analysis
What are the political factors affecting the Artificial Heart Lung Machines Market in 2025?
Government regulations and healthcare policies significantly impact the market, especially in terms of approvals and funding for medical technologies. Changes in reimbursement policies and healthcare accessibility can influence the affordability and adoption rates of artificial heart-lung machines in different regions.
What are the economic factors affecting the Artificial Heart Lung Machines Market in 2025?
The market will be influenced by the overall economic conditions, including healthcare budgets and spending capacity in both developed and emerging markets. High production and maintenance costs could hinder market expansion, particularly in countries with limited financial resources, while economic growth in emerging markets could offer new opportunities.
What are the social factors affecting the Artificial Heart Lung Machines Market in 2025?
An aging population and the rising incidence of heart and lung diseases are driving demand for artificial heart-lung machines. Societal awareness about advanced healthcare options and the willingness to invest in innovative medical treatments will also contribute to market growth.
What are the technological factors affecting the Artificial Heart Lung Machines Market in 2025?
Advancements in artificial heart-lung machine technology, including improvements in biocompatibility, miniaturization, and integration with AI for enhanced monitoring, will significantly impact the market. Ongoing research into more efficient and reliable devices could improve patient outcomes and make these machines more accessible.
What are the environmental factors affecting the Artificial Heart Lung Machines Market in 2025?
Environmental concerns regarding the disposal and sustainability of medical devices are becoming more prominent. The healthcare industry’s focus on reducing waste and improving eco-friendly production methods may push manufacturers to develop more sustainable heart-lung machines.
What are the legal factors affecting the Artificial Heart Lung Machines Market in 2025?
Strict regulations regarding medical device approvals, safety standards, and intellectual property rights play a critical role in the market. Legal challenges in patenting innovations or managing liability risks associated with machine malfunctions could affect the development and commercialization of artificial heart-lung machines.
Market SIPOC Analysis
Who are the suppliers in the Artificial Heart Lung Machines Market in 2025?
Suppliers include manufacturers of heart-lung machine components, such as pumps, oxygenators, and valves, as well as raw material suppliers for specialized medical-grade materials. Key suppliers also include those who provide technological software and sensors for machine monitoring and control.
What are the inputs in the Artificial Heart Lung Machines Market in 2025?
Inputs consist of high-quality materials for device manufacturing, such as polymers and metals, as well as advanced technology for device development. Research and development efforts, clinical trials, and regulatory approvals also play an important role as inputs to bring new heart-lung machines to market.
What are the processes involved in the Artificial Heart Lung Machines Market in 2025?
Processes include research and development of new technologies, design and engineering of heart-lung machines, manufacturing, quality control, and regulatory testing. The final stages involve distribution, sales, and installation, followed by post-sale services such as maintenance and upgrades.
Who are the customers in the Artificial Heart Lung Machines Market in 2025?
Customers include hospitals, surgical centers, and healthcare providers specializing in cardiac and pulmonary surgeries. Additionally, government health departments, as well as private healthcare institutions, are key customers that purchase or fund the purchase of these machines.
What are the outputs in the Artificial Heart Lung Machines Market in 2025?
Outputs include fully functional artificial heart-lung machines, including equipment designed for short- or long-term use in surgeries. Additionally, outputs include support services such as training for medical staff, maintenance, and the provision of data analytics tools to optimize machine performance during surgeries.
Market Porter's Five Forces
What is the threat of new entrants in the Artificial Heart Lung Machines Market in 2025?
The threat of new entrants is moderate. While the high capital requirements and strict regulatory standards limit the entry of new players, advancements in technology and growing market demand create opportunities for innovation. New entrants with breakthrough technologies could disrupt the market, but overcoming technical, financial, and regulatory barriers remains challenging.
What is the bargaining power of suppliers in the Artificial Heart Lung Machines Market in 2025?
The bargaining power of suppliers is moderate to high. The market depends on specialized suppliers for critical components like pumps, sensors, and oxygenators. Any disruptions in the supply chain or changes in raw material costs could impact the overall production process, giving suppliers some leverage.
What is the bargaining power of buyers in the Artificial Heart Lung Machines Market in 2025?
The bargaining power of buyers is moderate. While buyers, including hospitals and healthcare institutions, have the option to choose from various manufacturers, the specialized nature and high cost of heart-lung machines limit their ability to negotiate significant discounts. However, larger healthcare providers with more purchasing power can influence pricing to an extent.
What is the threat of substitute products in the Artificial Heart Lung Machines Market in 2025?
The threat of substitutes is moderate. While there are alternative devices like ventricular assist devices and extracorporeal membrane oxygenation (ECMO) systems, heart-lung machines are still considered essential for many high-risk surgeries. However, any significant breakthroughs in alternative treatments could reduce the demand for heart-lung machines in certain procedures.
What is the intensity of competitive rivalry in the Artificial Heart Lung Machines Market in 2025?
The intensity of competitive rivalry is high. The market is dominated by established players, and the competition is fierce in terms of technological advancements, product differentiation, and pricing. Manufacturers are constantly innovating to improve the performance, size, and portability of heart-lung machines to maintain their market position.
Market Upstream Analysis
What are the key upstream suppliers in the Artificial Heart Lung Machines Market in 2025?
Key upstream suppliers include manufacturers of specialized materials such as medical-grade metals, polymers, and composites. Additionally, companies that supply high-tech components, including pumps, sensors, oxygenators, and advanced electronics for monitoring and control systems, are crucial in the supply chain.
What are the main raw materials required in the Artificial Heart Lung Machines Market in 2025?
The main raw materials include biocompatible metals (such as titanium and stainless steel), high-performance polymers, silicone for seals, advanced electronics for monitoring systems, and specialized coatings to enhance device durability and functionality in the human body.
What are the challenges faced by upstream suppliers in the Artificial Heart Lung Machines Market in 2025?
Upstream suppliers face challenges related to the high cost and availability of specialized raw materials. Regulatory compliance is also a concern, as the materials and components used must meet stringent medical device standards. Additionally, supply chain disruptions, due to geopolitical factors or natural disasters, can impact production timelines and costs.
What impact do technological advancements have on upstream suppliers in the Artificial Heart Lung Machines Market in 2025?
Technological advancements drive the need for higher-quality, more precise materials, as well as the development of new components to support innovative heart-lung machine designs. Suppliers must continuously adapt to new technologies, ensuring that their products meet evolving performance standards and regulatory requirements.
How does the regulatory environment affect upstream suppliers in the Artificial Heart Lung Machines Market in 2025?
The regulatory environment greatly influences upstream suppliers, as they must comply with strict medical device standards set by authorities like the FDA and EMA. These regulations govern not only the materials used but also testing, manufacturing processes, and safety protocols, which can increase costs and time-to-market.
Market Midstream Analysis
What are the key players in the midstream of the Artificial Heart Lung Machines Market in 2025?
Key players in the midstream include manufacturers who assemble and integrate the components into fully functional artificial heart-lung machines. These players work closely with upstream suppliers for materials and components and play a crucial role in ensuring the final product meets medical standards and regulations. Major companies in this segment also handle quality control, device testing, and regulatory compliance.
What are the main processes involved in the midstream of the Artificial Heart Lung Machines Market in 2025?
The main processes involve the assembly and integration of critical components such as pumps, oxygenators, valves, and sensors. Testing and quality assurance are crucial steps to ensure the machines meet safety standards and function correctly during surgeries. Furthermore, certification and approval from regulatory bodies such as the FDA or EMA are essential before the devices can be distributed to hospitals and healthcare providers.
What challenges do midstream players face in the Artificial Heart Lung Machines Market in 2025?
Midstream players face challenges such as managing the complexity of integrating various high-tech components and ensuring the reliability of the final product. Additionally, adhering to evolving regulatory standards and maintaining a steady supply of components from upstream suppliers are ongoing concerns. The high cost of manufacturing and ensuring the quality of each machine can also pose significant hurdles.
How does technology impact the midstream of the Artificial Heart Lung Machines Market in 2025?
Technological advancements are driving the development of more compact, efficient, and user-friendly heart-lung machines. Midstream players must adapt to these innovations by integrating cutting-edge technologies such as AI-powered monitoring systems, improved biocompatible materials, and miniaturized components. This allows for more efficient production and better patient outcomes.
What role do regulatory requirements play in the midstream of the Artificial Heart Lung Machines Market in 2025?
Regulatory requirements are pivotal in the midstream process, as every device must undergo rigorous testing and certification to meet health and safety standards. Compliance with these standards ensures that heart-lung machines are safe for use in critical surgeries and meet global market requirements. Midstream players must be well-versed in navigating these regulations to ensure smooth approval processes and timely product launches.
Market Downstream Analysis
Who are the key stakeholders in the downstream of the Artificial Heart Lung Machines Market in 2025?
Key stakeholders include hospitals, surgical centers, and healthcare providers that purchase, use, and maintain artificial heart-lung machines. Additionally, healthcare professionals such as surgeons, cardiologists, and perfusionists play a critical role in the downstream process by utilizing these devices in surgeries. Medical device distributors and service providers also contribute to the downstream by ensuring timely delivery and maintenance.
What are the main activities in the downstream of the Artificial Heart Lung Machines Market in 2025?
The main activities involve the distribution and sale of heart-lung machines to healthcare institutions. Once purchased, hospitals and clinics are responsible for the installation, training of medical staff, and ongoing maintenance of the devices. Aftercare services, including technical support, repairs, and upgrades, are also integral to ensuring the long-term functionality and safety of the machines.
What challenges do downstream players face in the Artificial Heart Lung Machines Market in 2025?
Downstream players face challenges related to the high cost of acquiring and maintaining these advanced machines, which can limit access for some healthcare institutions, especially in developing regions. Additionally, the need for specialized training for healthcare professionals to operate these complex machines is a significant hurdle. Ensuring continuous maintenance and addressing potential device malfunctions are also important challenges.
How does technology influence the downstream of the Artificial Heart Lung Machines Market in 2025?
Technology influences the downstream by improving the functionality of heart-lung machines, with newer models featuring more advanced monitoring systems and automated processes. This enhances the overall user experience and patient safety. Furthermore, technological advancements in telemedicine and remote monitoring allow for more efficient management and maintenance of the devices, providing ongoing support to healthcare providers.
What is the impact of regulatory factors on the downstream of the Artificial Heart Lung Machines Market in 2025?
Regulatory factors significantly impact the downstream, as healthcare providers must adhere to strict guidelines when using heart-lung machines in clinical settings. Regulatory requirements ensure the safety and effectiveness of the devices, and compliance is necessary for both usage and maintenance. Additionally, ongoing inspections and certifications may be required for healthcare institutions to ensure that they are using the most up-to-date, compliant devices
Chapter 1, to describe Artificial Heart Lung Machines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Artificial Heart Lung Machines, with price, sales, revenue and global market share of Artificial Heart Lung Machines from 2018 to 2023.
Chapter 3, the Artificial Heart Lung Machines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Heart Lung Machines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Artificial Heart Lung Machines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Artificial Heart Lung Machines.
Chapter 14 and 15, to describe Artificial Heart Lung Machines sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Artificial Heart Lung Machines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Artificial Heart Lung Machines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Single Roller Pump HLM
1.3.3 Double Roller Pump HLM
1.4 Market Analysis by Application
1.4.1 Overview: Global Artificial Heart Lung Machines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cardiac Surgery
1.4.3 Lung Transplant Operation
1.4.4 Acute Respiratory Failure Treatment
1.4.5 Others
1.5 Global Artificial Heart Lung Machines Market Size & Forecast
1.5.1 Global Artificial Heart Lung Machines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Artificial Heart Lung Machines Sales Quantity (2018-2029)
1.5.3 Global Artificial Heart Lung Machines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 LivaNova (Sorin)
2.1.1 LivaNova (Sorin) Details
2.1.2 LivaNova (Sorin) Major Business
2.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Product and Services
2.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 LivaNova (Sorin) Recent Developments/Updates
2.2 Getinge (Maquet)
2.2.1 Getinge (Maquet) Details
2.2.2 Getinge (Maquet) Major Business
2.2.3 Getinge (Maquet) Artificial Heart Lung Machines Product and Services
2.2.4 Getinge (Maquet) Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Getinge (Maquet) Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Artificial Heart Lung Machines Product and Services
2.3.4 Medtronic Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Medtronic Recent Developments/Updates
2.4 Terumo CV Group
2.4.1 Terumo CV Group Details
2.4.2 Terumo CV Group Major Business
2.4.3 Terumo CV Group Artificial Heart Lung Machines Product and Services
2.4.4 Terumo CV Group Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Terumo CV Group Recent Developments/Updates
2.5 Braile Biomedica
2.5.1 Braile Biomedica Details
2.5.2 Braile Biomedica Major Business
2.5.3 Braile Biomedica Artificial Heart Lung Machines Product and Services
2.5.4 Braile Biomedica Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Braile Biomedica Recent Developments/Updates
2.6 Tianjin Medical
2.6.1 Tianjin Medical Details
2.6.2 Tianjin Medical Major Business
2.6.3 Tianjin Medical Artificial Heart Lung Machines Product and Services
2.6.4 Tianjin Medical Artificial Heart Lung Machines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Tianjin Medical Recent Developments/Updates
3 Competitive Environment: Artificial Heart Lung Machines by Manufacturer
3.1 Global Artificial Heart Lung Machines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Artificial Heart Lung Machines Revenue by Manufacturer (2018-2023)
3.3 Global Artificial Heart Lung Machines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Artificial Heart Lung Machines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Artificial Heart Lung Machines Manufacturer Market Share in 2022
3.4.2 Top 6 Artificial Heart Lung Machines Manufacturer Market Share in 2022
3.5 Artificial Heart Lung Machines Market: Overall Company Footprint Analysis
3.5.1 Artificial Heart Lung Machines Market: Region Footprint
3.5.2 Artificial Heart Lung Machines Market: Company Product Type Footprint
3.5.3 Artificial Heart Lung Machines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Artificial Heart Lung Machines Market Size by Region
4.1.1 Global Artificial Heart Lung Machines Sales Quantity by Region (2018-2029)
4.1.2 Global Artificial Heart Lung Machines Consumption Value by Region (2018-2029)
4.1.3 Global Artificial Heart Lung Machines Average Price by Region (2018-2029)
4.2 North America Artificial Heart Lung Machines Consumption Value (2018-2029)
4.3 Europe Artificial Heart Lung Machines Consumption Value (2018-2029)
4.4 Asia-Pacific Artificial Heart Lung Machines Consumption Value (2018-2029)
4.5 South America Artificial Heart Lung Machines Consumption Value (2018-2029)
4.6 Middle East and Africa Artificial Heart Lung Machines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Artificial Heart Lung Machines Sales Quantity by Type (2018-2029)
5.2 Global Artificial Heart Lung Machines Consumption Value by Type (2018-2029)
5.3 Global Artificial Heart Lung Machines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Artificial Heart Lung Machines Sales Quantity by Application (2018-2029)
6.2 Global Artificial Heart Lung Machines Consumption Value by Application (2018-2029)
6.3 Global Artificial Heart Lung Machines Average Price by Application (2018-2029)
7 North America
7.1 North America Artificial Heart Lung Machines Sales Quantity by Type (2018-2029)
7.2 North America Artificial Heart Lung Machines Sales Quantity by Application (2018-2029)
7.3 North America Artificial Heart Lung Machines Market Size by Country
7.3.1 North America Artificial Heart Lung Machines Sales Quantity by Country (2018-2029)
7.3.2 North America Artificial Heart Lung Machines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Artificial Heart Lung Machines Sales Quantity by Type (2018-2029)
8.2 Europe Artificial Heart Lung Machines Sales Quantity by Application (2018-2029)
8.3 Europe Artificial Heart Lung Machines Market Size by Country
8.3.1 Europe Artificial Heart Lung Machines Sales Quantity by Country (2018-2029)
8.3.2 Europe Artificial Heart Lung Machines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Artificial Heart Lung Machines Market Size by Region
9.3.1 Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Artificial Heart Lung Machines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Artificial Heart Lung Machines Sales Quantity by Type (2018-2029)
10.2 South America Artificial Heart Lung Machines Sales Quantity by Application (2018-2029)
10.3 South America Artificial Heart Lung Machines Market Size by Country
10.3.1 South America Artificial Heart Lung Machines Sales Quantity by Country (2018-2029)
10.3.2 South America Artificial Heart Lung Machines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Artificial Heart Lung Machines Market Size by Country
11.3.1 Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Artificial Heart Lung Machines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Artificial Heart Lung Machines Market Drivers
12.2 Artificial Heart Lung Machines Market Restraints
12.3 Artificial Heart Lung Machines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Artificial Heart Lung Machines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Artificial Heart Lung Machines
13.3 Artificial Heart Lung Machines Production Process
13.4 Artificial Heart Lung Machines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Artificial Heart Lung Machines Typical Distributors
14.3 Artificial Heart Lung Machines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Artificial Heart Lung Machines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Artificial Heart Lung Machines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. LivaNova (Sorin) Basic Information, Manufacturing Base and Competitors
Table 4. LivaNova (Sorin) Major Business
Table 5. LivaNova (Sorin) Artificial Heart Lung Machines Product and Services
Table 6. LivaNova (Sorin) Artificial Heart Lung Machines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. LivaNova (Sorin) Recent Developments/Updates
Table 8. Getinge (Maquet) Basic Information, Manufacturing Base and Competitors
Table 9. Getinge (Maquet) Major Business
Table 10. Getinge (Maquet) Artificial Heart Lung Machines Product and Services
Table 11. Getinge (Maquet) Artificial Heart Lung Machines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Getinge (Maquet) Recent Developments/Updates
Table 13. Medtronic Basic Information, Manufacturing Base and Competitors
Table 14. Medtronic Major Business
Table 15. Medtronic Artificial Heart Lung Machines Product and Services
Table 16. Medtronic Artificial Heart Lung Machines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Medtronic Recent Developments/Updates
Table 18. Terumo CV Group Basic Information, Manufacturing Base and Competitors
Table 19. Terumo CV Group Major Business
Table 20. Terumo CV Group Artificial Heart Lung Machines Product and Services
Table 21. Terumo CV Group Artificial Heart Lung Machines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Terumo CV Group Recent Developments/Updates
Table 23. Braile Biomedica Basic Information, Manufacturing Base and Competitors
Table 24. Braile Biomedica Major Business
Table 25. Braile Biomedica Artificial Heart Lung Machines Product and Services
Table 26. Braile Biomedica Artificial Heart Lung Machines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Braile Biomedica Recent Developments/Updates
Table 28. Tianjin Medical Basic Information, Manufacturing Base and Competitors
Table 29. Tianjin Medical Major Business
Table 30. Tianjin Medical Artificial Heart Lung Machines Product and Services
Table 31. Tianjin Medical Artificial Heart Lung Machines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Tianjin Medical Recent Developments/Updates
Table 33. Global Artificial Heart Lung Machines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Artificial Heart Lung Machines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Artificial Heart Lung Machines Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 36. Market Position of Manufacturers in Artificial Heart Lung Machines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Artificial Heart Lung Machines Production Site of Key Manufacturer
Table 38. Artificial Heart Lung Machines Market: Company Product Type Footprint
Table 39. Artificial Heart Lung Machines Market: Company Product Application Footprint
Table 40. Artificial Heart Lung Machines New Market Entrants and Barriers to Market Entry
Table 41. Artificial Heart Lung Machines Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Artificial Heart Lung Machines Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Artificial Heart Lung Machines Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Artificial Heart Lung Machines Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Artificial Heart Lung Machines Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Artificial Heart Lung Machines Average Price by Region (2018-2023) & (USD/Unit)
Table 47. Global Artificial Heart Lung Machines Average Price by Region (2024-2029) & (USD/Unit)
Table 48. Global Artificial Heart Lung Machines Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Artificial Heart Lung Machines Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Artificial Heart Lung Machines Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Artificial Heart Lung Machines Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Artificial Heart Lung Machines Average Price by Type (2018-2023) & (USD/Unit)
Table 53. Global Artificial Heart Lung Machines Average Price by Type (2024-2029) & (USD/Unit)
Table 54. Global Artificial Heart Lung Machines Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Artificial Heart Lung Machines Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Artificial Heart Lung Machines Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Artificial Heart Lung Machines Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Artificial Heart Lung Machines Average Price by Application (2018-2023) & (USD/Unit)
Table 59. Global Artificial Heart Lung Machines Average Price by Application (2024-2029) & (USD/Unit)
Table 60. North America Artificial Heart Lung Machines Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Artificial Heart Lung Machines Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Artificial Heart Lung Machines Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Artificial Heart Lung Machines Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Artificial Heart Lung Machines Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Artificial Heart Lung Machines Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Artificial Heart Lung Machines Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Artificial Heart Lung Machines Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Artificial Heart Lung Machines Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Artificial Heart Lung Machines Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Artificial Heart Lung Machines Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Artificial Heart Lung Machines Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Artificial Heart Lung Machines Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Artificial Heart Lung Machines Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Artificial Heart Lung Machines Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Artificial Heart Lung Machines Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Artificial Heart Lung Machines Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Artificial Heart Lung Machines Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Artificial Heart Lung Machines Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Artificial Heart Lung Machines Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Artificial Heart Lung Machines Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Artificial Heart Lung Machines Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Artificial Heart Lung Machines Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Artificial Heart Lung Machines Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Artificial Heart Lung Machines Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Artificial Heart Lung Machines Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Artificial Heart Lung Machines Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Artificial Heart Lung Machines Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Artificial Heart Lung Machines Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Artificial Heart Lung Machines Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Artificial Heart Lung Machines Raw Material
Table 101. Key Manufacturers of Artificial Heart Lung Machines Raw Materials
Table 102. Artificial Heart Lung Machines Typical Distributors
Table 103. Artificial Heart Lung Machines Typical Customers
List of Figures
Figure 1. Artificial Heart Lung Machines Picture
Figure 2. Global Artificial Heart Lung Machines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Artificial Heart Lung Machines Consumption Value Market Share by Type in 2022
Figure 4. Single Roller Pump HLM Examples
Figure 5. Double Roller Pump HLM Examples
Figure 6. Global Artificial Heart Lung Machines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Artificial Heart Lung Machines Consumption Value Market Share by Application in 2022
Figure 8. Cardiac Surgery Examples
Figure 9. Lung Transplant Operation Examples
Figure 10. Acute Respiratory Failure Treatment Examples
Figure 11. Others Examples
Figure 12. Global Artificial Heart Lung Machines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Artificial Heart Lung Machines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Artificial Heart Lung Machines Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Artificial Heart Lung Machines Average Price (2018-2029) & (USD/Unit)
Figure 16. Global Artificial Heart Lung Machines Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Artificial Heart Lung Machines Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Artificial Heart Lung Machines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Artificial Heart Lung Machines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Artificial Heart Lung Machines Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Artificial Heart Lung Machines Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Artificial Heart Lung Machines Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Artificial Heart Lung Machines Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Artificial Heart Lung Machines Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Artificial Heart Lung Machines Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Artificial Heart Lung Machines Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Artificial Heart Lung Machines Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Artificial Heart Lung Machines Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Artificial Heart Lung Machines Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Artificial Heart Lung Machines Average Price by Type (2018-2029) & (USD/Unit)
Figure 31. Global Artificial Heart Lung Machines Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Artificial Heart Lung Machines Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Artificial Heart Lung Machines Average Price by Application (2018-2029) & (USD/Unit)
Figure 34. North America Artificial Heart Lung Machines Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Artificial Heart Lung Machines Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Artificial Heart Lung Machines Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Artificial Heart Lung Machines Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Artificial Heart Lung Machines Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Artificial Heart Lung Machines Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Artificial Heart Lung Machines Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Artificial Heart Lung Machines Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Artificial Heart Lung Machines Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Artificial Heart Lung Machines Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Artificial Heart Lung Machines Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Artificial Heart Lung Machines Consumption Value Market Share by Region (2018-2029)
Figure 54. China Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Artificial Heart Lung Machines Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Artificial Heart Lung Machines Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Artificial Heart Lung Machines Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Artificial Heart Lung Machines Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Artificial Heart Lung Machines Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Artificial Heart Lung Machines Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Artificial Heart Lung Machines Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Artificial Heart Lung Machines Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Artificial Heart Lung Machines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Artificial Heart Lung Machines Market Drivers
Figure 75. Artificial Heart Lung Machines Market Restraints
Figure 76. Artificial Heart Lung Machines Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Artificial Heart Lung Machines in 2022
Figure 79. Manufacturing Process Analysis of Artificial Heart Lung Machines
Figure 80. Artificial Heart Lung Machines Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
